Search Results 1661-1670 of 21455 for platelets

1. Interferon alfa-2b (injection route) - Side effects & uses - Mayo Clinic

   It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take ...

2. A Study To Assess The Feasibility And Safety Of Intratumoral Diffusing Alpha Emitters For The Treatment Of Recurrent Glioblastoma - Mayo Clinic

   ... Platelet count ≥ 100,000/mm3 (80 × 109/L) Hemoglobin (Hgb) ≥ 9 g/dL. Patients must have the following blood chemistry levels at initial screening obtained ...

3. VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer - Mayo Clinic

   Platelet Count (PLT) ≥00,000/μL;; Hemoglobin ≥10 g/dL;; Creatinine ≤2.0 mg/dL;; AST and ALT ≤2 x upper limit of normal (ULN);. NOTE: If baseline liver ...

4. Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery - Mayo Clinic

   Platelets >= 50 B/L (10^9/L); Total bilirubin =< 3 × institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) (serum glutamic oxaloacetic ...

5. A Study to Evaluate Daratumumab in Treating Transplant-Eligible Participants with Multiple Myeloma - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC) ≥ 1,000 cell/mm3 without growth factor support; · Platelets ≥ 50,000 cells/mm3 for patients who have ...

6. A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Platelets < 100,000/mm3 (<3 x 109/L); Serum creatinine > 2 x ULN; Serum ALT or AST > 2 x ULN. Severe skin thickening (mRSS 3) on the inner aspects of thighs ...

7. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   Known history of platelet transfusion for chemotherapy-induced thrombocytopenia or persistent (> 4 weeks) ≥ Grade 3 hematological toxicity or fatigue from ...

8. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   Marrow: Peripheral blood leukocyte count (WBC) < 3000/mm3, absolute neutrophil count ≤ 1500/mm3, platelets < 75000/mm3, or hemoglobin < 10 gm/dL; Hepatic ...

9. A Study of Carboplatin, Cabazitaxel and Abiraterone in High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) - Mayo Clinic

   Platelets ≥ 100 × 10^9 /L;; Hemoglobin ≥ 9 g/dl;; Serum creatinine ≤ 1.5mg/dL or estimated creatinine clearance ≥ 50 ml/min;; In the absence of liver ...

10. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

    Platelet count < 120,000/mm3; Total bilirubin > 3 times the upper limit of normal (ULN); Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ...